Abstract:Autism spectrum disorder (ASD) is a complex neurological developmental disorder in children, and is associated with social isolation and restricted interests. The etiology of this disorder is still unknown. There is neither any confirmed laboratory test nor any effective therapeutic strategy to diagnose or cure it. We performed data independent acquisition (DIA) and multiple reaction monitoring (MRM) analysis of plasma from children with ASD and controls. The result showed that 45 differentially expressed proteins (DEPs) were identified between autistic subjects and controls. Among these, only one DEP was down-regulated in ASD; other DEPs were up-regulated in ASD children's plasma. These proteins are found associated with complement and coagulation cascades, vitamin digestion and absorption, cholesterol metabolism, platelet degranulation, selenium micronutrient network, extracellular matrix organization and inflammatory pathway, which have been reported to be related to ASD. After MRM verification, five key proteins in complement pathway (PLG, SERPINC1, and A2M) and inflammatory pathway (CD5L, ATRN, SERPINC1, and A2M) were confirmed to be significantly up-regulated in ASD group. Through the screening of machine learning model and MRM verification, we found that two proteins (biotinidase and carbonic anhydrase 1) can be used as early diagnostic markers of ASD (AUC = 0.8, p = 0.0001). Significance: ASD is the fastest growing neurodevelopmental disorder in the world and has become a major public health problem worldwide. Its prevalence has been steadily increasing, with a global prevalence rate of 1%. Early diagnosis and intervention can achieve better prognosis. In this study, data independent acquisition (DIA) and multiple reaction monitoring (MRM) analysis was applied to analyze the plasma proteome of ASD patients (31 (+/- 5) months old), and 378 proteins were quantified. 45 differentially expressed proteins (DEPs) were identified between the ASD group and the control group. They mainly were associated with platelet degranulation, ECM proteoglycar, complement and coagulation cascades, selenium micronutrient network, regulation of insulin-like growth factor (IGF) transport and uptake by insulin-like growth factor binding proteins (IGFBPs), cholesterol metabolism, vitamin metabolism, and inflammatory pathway. Through the integrated machine learning methods and the MRM verification of independent samples, it is considered that biotinidase and carbon anhydrase 1 have the potential to become biomarkers for the early diagnosis of ASD. These results complement proteomics database of the ASD patients, broaden our understanding of ASD, and provide a panel of biomarkers for the early diagnosis of ASD.

Whole-transcriptome Analysis of Serum Neuron-Derived Exosomes Reveals Specific Signature for Autism Spectrum Disorder in Chinese Children

Whole-Transcriptome Analysis of Serum L1CAM-Captured Extracellular Vesicles Reveals Neural and Glycosylation Changes in Autism Spectrum Disorder

Peptidome Analysis Reveals Novel Serum Biomarkers for Children with Autism Spectrum Disorder in China.

Serum microRNA profiles in children with autism

A Combined Proteomics and Metabolomics Profiling to Investigate the Genetic Heterogeneity of Autistic Children

The Use of Data Independent Acquisition Based Proteomic Analysis and Machine Learning to Reveal Potential Biomarkers for Autism Spectrum Disorder.

Serum Glycopattern and Maackia Amurensis Lectin-Ii Binding Glycoproteins in Autism Spectrum Disorder

Integration of Urine Proteomic and Metabolomic Profiling Reveals Novel Insights into Neuroinflammation in Autism Spectrum Disorder

Identification of De Novo Mutations in the Chinese Autism Spectrum Disorder Cohort Via Whole-Exome Sequencing Unveils Brain Regions Implicated in Autism

Biomarkers and pathways in autism spectrum disorder: An individual meta-analysis based on proteomic and metabolomic data

A Proteomic Analysis of Urine Biomarkers in Autism Spectrum Disorder

Artificial intelligence and bioinformatics analyze markers of children's transcriptional genome to predict autism spectrum disorder

Expression and Regulatory Network Analysis of miR-140-3p, a New Potential Serum Biomarker for Autism Spectrum Disorder

Correlation Between Sialidase NEU1 Mrna Expression Changes in Autism Spectrum Disorder

Differential Metabolites in Chinese Autistic Children: A Multi-Center Study Based on Urinary 1H-NMR Metabolomics Analysis

Proteomics Study of Peripheral Blood Mononuclear Cells (PBMCs) in Autistic Children

A Systematic Investigation of Complement and Coagulation-Related Protein in Autism Spectrum Disorder Using Multiple Reaction Monitoring Technology

Identification of Amino Acid Dysregulation as a Potential Biomarker for Autism Spectrum Disorder in China

Discovery and Validation of Novel Genes in a Large Chinese Autism Spectrum Disorder Cohort.

Gut microbiome and serum amino acid metabolome alterations in autism spectrum disorder

Potential of gut microbiome for detection of autism spectrum disorder